Nordea cuts stance on AstraZeneca.
NORDIC BUSINESS REPORT-31 May 2010-Nordea cuts stance on AstraZeneca(C)1994-2010 M2 COMMUNICATIONS http://www.m2.com
31 May 2010 - Nordea downgraded on Monday its rating on Anglo-Swedish pharma major AstraZeneca (STO: AZN) (NYSE: AZN) to "sell" from "hold", cutting the share price target to USD41 from USD49.
Last Friday, the American depository receipt (ADR) in AstraZeneca closed at USD42.25 on the New York Stock Exchange. In Stockholm, the company's shares had edged down 0.70% to SEK326.70 by 11:42 CET on Monday.
(EUR1 = USD1.2; EUR1 = SEK9.6)
((Comments on this story may be sent to email@example.com))